← Back to Search

Beta Blocker

Propranolol for Prolonged Pregnancy (PROPEL Trial)

Phase 3
Waitlist Available
Led By Lisa Levine, MD, MSCE
Research Sponsored by Lisa Levine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from start of labor through delivery
Awards & highlights

PROPEL Trial Summary

This trial found that propranolol given to women in labor can help speed up the process and reduce the likelihood of needing a c-section.

PROPEL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from delivery through hospital discharge, usually 2-4 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and from delivery through hospital discharge, usually 2-4 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mode of Delivery
Secondary outcome measures
Chorioamnionitis
Length of Labor
Maternal Morbidity
+2 more

PROPEL Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: PropranololActive Control1 Intervention
IV Propranolol - 2mg; one possible repeat dose ≥2 hours later
Group II: PlaceboPlacebo Group1 Intervention
Normal saline placebo- 2 mL; one possible repeat dose ≥2 hours later

Find a Location

Who is running the clinical trial?

Lisa LevineLead Sponsor
Lisa Levine, MD, MSCEPrincipal Investigator - University of Pennsylvania
Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital
1 Previous Clinical Trials
2,300 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~35 spots leftby Apr 2025